98%
921
2 minutes
20
Objective: The purpose of this study was to explore longitudinal changes in synaptic density after ischemic stroke in vivo with synaptic vesicle protein 2A (SV2A) positron emission tomography (PET).
Methods: We recruited patients with an ischemic stroke to undergo C-UCB-J PET/MR within the first month and 6 months after the stroke. We investigated longitudinal changes of partial volume corrected C-UCB-J standardized uptake value ratio (SUVR; relative to centrum semiovale) within the ischemic lesion, peri-ischemic area and unaffected ipsilesional and contralesional grey matter. We also explored crossed cerebellar diaschisis at 6 months. Additionally, we defined brain regions potentially influencing upper limb motor recovery after stroke and studied C-UCB-J SUVR evolution in comparison to baseline.
Results: In 13 patients (age = 67 ± 15 years) we observed decreasing C-UCB-J SUVR in the ischemic lesion (ΔSUVR = -1.0, p = 0.001) and peri-ischemic area (ΔSUVR = -0.31, p = 0.02) at 6 months after stroke compared to baseline. Crossed cerebellar diaschisis as measured with C-UCB-J SUVR was present in 11 of 13 (85%) patients at 6 months. The C-UCB-J SUVR did not augment in ipsilesional or contralesional brain regions associated with motor recovery. On the contrary, there was an overall trend of declining C-UCB-J SUVR in these brain regions, reaching statistical significance only in the nonlesioned part of the ipsilesional supplementary motor area (ΔSUVR = -0.83, p = 0.046).
Interpretation: At 6 months after stroke, synaptic density further declined in the ischemic lesion and peri-ischemic area compared to baseline. Brain regions previously demonstrated to be associated with motor recovery after stroke did not show increases in synaptic density. ANN NEUROL 2023;93:911-921.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ana.26593 | DOI Listing |
Alzheimers Dement
December 2024
Turku PET Centre, University of Turku, Turku, Finland.
J Nucl Med
November 2024
Alzheimer's Disease Research Unit, Yale School of Medicine, New Haven, Connecticut;
Simplified methods of acquisition and quantification would facilitate the use of synaptic density imaging in multicenter and longitudinal studies of Alzheimer disease (AD). We validated a simplified tissue-to-reference ratio method using SUV ratios (SUVRs) for estimating synaptic density with [C]UCB-J PET. Participants included 31 older adults with AD and 16 with normal cognition.
View Article and Find Full Text PDFSci Rep
February 2024
Madison School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Down syndrome (DS) is the most prevalent genetic cause of intellectual disability, resulting from trisomy 21. Recently, positron emission tomography (PET) imaging has been used to image synapses in vivo. The motivation for this pilot study was to investigate whether synaptic density in low functioning adults with DS can be evaluated using the PET radiotracer [C]UCB-J.
View Article and Find Full Text PDFJ Cereb Blood Flow Metab
December 2023
Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
For some positron emission tomography studies, radiotracer is administered as bolus plus continuous infusion (B/I) to achieve a state of equilibrium. This approach can reduce scanning time and simplify data analysis; however, the method must be validated and optimized for each tracer. This study aimed to validate a B/I method for quantification of synaptic density using radiotracers which target the synaptic vesicle glycoprotein 2 A: [C]UCB-J and [F]SynVesT-1.
View Article and Find Full Text PDFMov Disord
October 2023
Department of Neurosciences, Neuropsychiatry, Leuven Brain Institute, KU Leuven, Leuven, Belgium.
Objective: To investigate whether mild motor signs (MMS) in old age correlate with synaptic density in the brain.
Background: Normal aging is associated with a decline in movement quality and quantity, commonly termed "mild parkinsonian signs" or more recently MMS. Whether MMS stem from global brain aging or pathology within motor circuits remains unresolved.